Basic information Safety Supplier Related

Atopaxar

Basic information Safety Supplier Related

Atopaxar Basic information

Product Name:
Atopaxar
Synonyms:
  • (943239-67-6) atopaxar
  • Atopaxar (E 5555)
  • CS-666
  • ER 172594-00
  • 2-(5,6-Diethoxy-7-fluoro-1,3-dihydro-1-imino-2H-isoindol-2-yl)-1-[3-(1,1-dimethylethyl)-4-methoxy-5-(4-morpholinyl)phenyl]ethanone
  • Atopaxar
  • E 5555
  • 1-(3-tert-butyl-4-Methoxy-5-Morpholino-phenyl)-2-(5,6-diethoxy-7-fluoro-1-iMino-1,3-dihydro-isoindol-2-yl)-ethanone
CAS:
751475-53-3
MF:
C29H38FN3O5
MW:
527.63
Product Categories:
  • Inhibitors
Mol File:
751475-53-3.mol
More
Less

Atopaxar Chemical Properties

Boiling point:
671.0±65.0 °C(Predicted)
Density 
1.22
storage temp. 
Store at -20°C
solubility 
DMSO : 250 mg/mL (473.82 mM; Need ultrasonic)
pka
7.43±0.20(Predicted)
More
Less

Atopaxar Usage And Synthesis

Definition

ChEBI: Atopaxar is an aromatic ketone.

Biological Activity

Atopaxar (E5555) is a potent, orally active, selective, reversible thrombin receptor protease-activated receptor-1 (PAR-1) antagonist. It can be used in the study of atherothrombotic diseases and interferes with platelet signaling..

in vitro

Atopaxar inhibits haTRAP (high-affinity thrombin receptor activating peptide) binding to PAR-1 on human platelet membranes in a concentration-dependent manner, with an IC 50 of 0.019 μM. < br/> Atopaxar inhibits human platelet aggregation induced by thrombin or TRAP in a concentration-dependent manner.
Atopaxar does not inhibit PRP (platelet-rich plasma) aggregation induced by ADP, U46619, collagen, and PAR-4ap, up to a concentration of 20 μM.

in vivo

Atopaxar (30-100 mg/kg; po) causes a dose-dependent prolongation of the time to occlusion of the femoral artery in photochemically-induced thrombosis (PIT) guinea pigs model.
Atopaxar does not prolong bleeding time in guinea pigs at the highest tested dosage of 1000 mg/kg.

< td class="col1 fwb"> Result:
Animal Model: Guinea pigs, PIT model
Dosage: Oral administration
Administration: 10 mg/kg, 30 mg/kg, 100 mg/kg
Prolonged the time to occlusion by 1.8-fold and 2.4-fold at 30 mg/kg and 100 mg/kg, respectively, compared with controls.

target

PAR-1

AtopaxarSupplier

Shanghai Luofa Biochemical Technology Co., Ltd. Gold
Tel
021-51111890 15317326293
Email
sales@molnova.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Shanghai Race Chemical Co., Ltd.
Tel
86-021-54933292
Email
sales@racechemical.com
DebyeTec.com Inc.
Tel
18086626237 18086626237
Email
sales@debyesci.com
Target molecule Corp.
Tel
857-239-0968
Email
service1@targetmol.com
More
Less